
News|Articles|June 1, 2002
- Pharmaceutical Technology-06-02-2002
- Volume 26
- Issue 6
Drug Shortages Reveal GMP Concerns
Author(s)Jill Wechsler
FDA cites manufacturing difficulties as a main contributing factor to recent drug shortages, which mainly involve injectibles and vaccines.
Advertisement
Articles in this issue
about 24 years ago
Excipient GMP Quality Standards: One is Enoughabout 24 years ago
The IPEC-Americas Excipient Master File Guideabout 24 years ago
Technology Advances Anticounterfeiting Optionsabout 24 years ago
Calibration of Lyophilization Pressure Gaugesabout 24 years ago
Outsourcing Outlookabout 24 years ago
Optimizing Cross-Organizational Team Performance and Managementabout 24 years ago
Screening for Counterfeit Drugs Using Near-Infrared Spectroscopyabout 24 years ago
Building on Tradition: Integrating the Links of ExpertiseAdvertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Why Eli Lilly Chose Pennsylvania for its $3.5B Facility
2
Implications of FDA Granting Priority Review to AZ's Ravulizumab
3
Optimizing Impact for Rare Diseases
4
Overcoming Fill-Finish Capacity Bottlenecks in Automated Pen Injector Assembly Lines
5




